Prelude Capital Management’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Sell
24,296
-19,036
-44% -$184K 0.02% 854
2025
Q4
$438K Buy
43,332
+9,998
+30% +$99.4K 0.03% 598
2025
Q3
$358K Buy
33,334
+16,544
+99% +$185K 0.03% 635
2025
Q2
$228K Sell
16,790
-726
-4% -$10.1K 0.02% 743
2025
Q1
$223K Sell
17,516
-19,810
-53% -$281K 0.02% 873
2024
Q4
$449K Buy
37,326
+6,715
+22% +$70.9K 0.03% 634
2024
Q3
$276K Buy
+30,611
New +$266K 0.02% 906

Other funds holding DCTH

Prelude Capital Management's DCTH Position: Q1 2026 in Review

Prelude Capital Management reduced its Delcath Systems (DCTH) stake by 44% in Q1 2026, selling an estimated $184K and leaving 24,296 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #854.

Prelude Capital Management first reported a position in DCTH in Q3 2024 and has held it in 7 quarters since. The position peaked at $449K in Q4 2024. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • Prelude Capital Management held 24,296 shares of Delcath Systems worth $225K as of Q1 2026.
  • Prelude Capital Management sold 19,036 Delcath Systems shares in Q1 2026, an estimated $184K.
  • Delcath Systems made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #854 holding.
  • Prelude Capital Management first reported a position in Delcath Systems in Q3 2024 and has held it in 7 quarters since.
  • Prelude Capital Management's Delcath Systems position peaked at $449K in Q4 2024.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.